Resident ID: ___-___-_____
Nursing Home Prevalence Survey: Resident Infection From
Survey Date: // Date Form Completed: // Data Collected by: _____ (initials)
For local use only, will not be Transmitted to CDC
Resident Name:__________________________________ Medical Record Number: ___________________ |
This form is being completed because the resident (check one): |
was receiving systemic antimicrobials |
had condition that may indicate infection |
The date of interest is: |
Antimicrobial start date: / / |
Prevalence survey date: / / |
The time period of interest for chart review begins: |
7 days before the antimicrobial start date, beginning on / / |
7 days before the survey date, beginning on / /
|
Date of first sign or symptom onset: / /
First sign or symptom onset occurred while resident was in: This facility Prior to admission |
|
|
Section A: Constitutional signs and symptoms: CHECK ALL THAT APPLY |
|
Check here if after your review NO constitutional signs or symptoms are documented |
|
Acute change in mental status from baseline WERE ANY OF THE FOLLOWING DOCUMENTED: Fluctuating: Behavior fluctuating (e.g., coming and Going, or change in severity during assessment) Inattention: Difficulty focusing attention ( e.g., unable to keep track of discussion or easily distracted) Disorganized thinking: Thinking is incoherent (e.g., rambling conversation, unclear flow of ideas, unpredictable switched in subject) Altered consciousness: Level described as different from baseline (Hyperalert, sleepy, drowsy, difficult to arouse, nonresponsive) Confusion Other , please specify:______________________________
|
Acute functional decline: increase in assistance with activities of daily living (ADL) from baseline WAS AN INCREASES IN LEVEL OF ASSISTANCE REQUIRED FOR ANY OF THE FOLLOWING DOCUMENTED: Bed mobility Transfer Locomotion within the facility Dressing Toilet use Personal hygiene Eating
|
Rigors or chills
Myalgias or body aches
Malaise
Loss of appetite or decreased oral intake
New-onset hypotension
Respiratory rate >=25 breaths per minute
Decreased oxygenation Select which of the following were documented: Pulse oximetry with single O2 saturation reading of <94% Pulse oximetry with single O2 saturation reading showing reduction of 3% from baseline Resident newly placed on oxygen
Leukocytosis Select which of the following were documented: Neutrophilia (>14,000 leukocytes/mm3) Left shift (6% bands or ≥1,500 bands/mm3) |
Fever SELECT WHICH OF THE FOLLOWING WERE DOCUMENTED: Single temperature >37.8oC (>100oF) Repeated temperatures >37.2oC (99oF) Single temperature >1.1oC (2oF) over baseline Term “Fever” is documented, but temperature value is not recorded
New hypothermia (<34.5oC, or does not register on the thermometer being used)
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section B: Urinary tract infection signs, symptoms, or tests |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check here if after your review NO urinary tract signs, symptoms or tests are documented |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDWELLING URINARY CATHETER status at the time of urinary sign/symptom onset: Resident without an indwelling urinary catheter Resident with an indwelling urinary catheter
This resident had documentation of provider suspected or diagnosed urinary tract infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section C: Respiratory tract infection signs, symptoms or tests |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check here if after your review NO respiratory tract signs, symptoms or tests are documented |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):
This resident has documentation of provider suspected or diagnosed Cold Pharyngitis Influenza-like illness Lower respiratory infection Pneumonia Other respiratory tract infection, please specify: ________________________
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section D: Skin, soft tissue, bone, joint, and mucosal infection signs, symptoms, or tests |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check here if after your review NO skin, soft tissue, bone, joint, or mucosal signs, symptoms or tests are documented |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):
Pus present at the affected wound, skin, or soft tissue site
Presence of inflammation at the affected wound or skin or soft tissue site SELECT WHICH OF THE FOLLOWING WERE DOCUMENTED: Heat at the affected site Redness at the affected site Serous drainage at the affected site Tenderness or pain at the affected site Swelling at the affected site
A topical antibiotic was applied at affected site (e.g., ointment or cream). Name of topical agent:________________
The affected site is:________________________
This resident has documentation of provider suspected or diagnosed Wound infection Cellulitis Osteomyelitis Joint infection Other, please specify: ________________________ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SUSPECTED SCABIES: INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): Maculopapular and/or itching rash Laboratory confirmation (positive scraping or biopsy) Epidemiological linkage to a case of scabies with lab confirmation Provider diagnosis of scabies Scabies other:___________________________
SUSPECTED FUNGAL SKIN or ORAL/PERIORAL INFECTION: INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): Presence of raises white patches in inflamed mucosa or plaques on oral mucosa Provider diagnosis of oral candidiasis Characteristic skin rash or skin lesion Lab confirmed fungal pathogen from skin scraping or biopsy Provider diagnosis of fungal skin infection Fungal other:___________________________
SUSPECTED HERPES SIMPLEX OR ZOSTER INFECTION: INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): Vesicular rash Laboratory confirmation of herpes simplex or herpes zoster infection Provider diagnosis of herpes simplex Provider diagnosis of herpes zoster infection Herpes other:___________________________
**Section D continues on the next page**
SUSPECTED CONJUNCTIVITIS (“Pink eye”) INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): Pus appearing from one or both eyes, present for at least 24 hours New or increased conjunctival erythema, with or without itching New or increased conjunctival pain, present for at least 24 hours. Topical antimicrobial applied to eyes (e.g., ointment or drops) NO documentation that conjunctivitis symptoms (“pink eye”) symptoms are due of allergic reaction or trauma Provider diagnosis of conjunctivitis
SUSPECTED EAR INFECTION INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): New drainage from one or both ears Ear pain Ear tenderness Topical antimicrobial applied to ears (e.g., ointment or drops) Provider diagnosis of an ear infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section E: Gastrointestinal tract infection signs, symptoms or tests |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check here if after your review NO gastrointestinal signs, symptoms or tests are documented |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY): Diarrhea Exceeds or equivalent to: 3 liquid or watery stools in 24-h period Diarrhea is documented, but frequency and/or time-period not known Vomiting Exceeds or equivalent to: 2 episodes in 24-h period Vomiting is documented but frequency and/or time-period not known Nausea Abdominal pain or tenderness Documentation of a noninfectious cause of diarrhea, vomiting or nausea, Specify:_________________________________________________
The resident has documentation of provider suspected or diagnosed C. difficile infection Gastroenteritis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section F: Bloodstream Infection, sepsis, blood cultures |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check here if after your review NO bloodstream infection or sepsis is documented |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):
The resident has documentation of provider suspected or diagnosed Bloodstream infection Sepsis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section G: Any other infections or relevant information |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Section H: Selected Antimicrobial Susceptibilities |
Check here if NO organisms were isolated or if the organism isolated if NOT one of those listed below - Data collection is now complete |
If one or more of the organism listed below was isolated from a specimen collected, check the box for the organism(s) and report the susceptibility result for the indicated antimicrobial agents. If 2 or more strains of the same organism are identified, enter the susceptibility pattern for the first organism isolated (by date). |
|||||||||||||||||
Organism name [code] |
OX/METH |
VANC |
LINZ |
TMZ
|
AMP |
CEFZN |
AMP-SUL |
PIP-TAZO |
CIPRO |
LEVO |
CEFTRX |
CEFTAZ |
CEFEP |
GENT |
IMI |
MERO |
|
|
S. aureus [SA] |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
|
S R N/A |
|
|
|
|
|
|
|
|
|
|
|
Enterococcus spp. [ENTFM or ENTFS] |
S R N/A |
S R N/A |
S R N/A |
|
S R N/A |
|
|
|
|
|
|
|
|
|
|
|
|
E. coli [EC] |
|
|
|
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
|
Klebsiella pneumoniae or oxytoca [KP or KO] |
|
|
|
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
|
Proteus mirabilis [PM] |
|
|
|
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
|
Enterobacter cloacae [ENC] |
|
|
|
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
|
Pseudomonas aeruginosa [PA] |
|
|
|
|
|
|
|
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
|
Acinetobacter baumanii [ACBA] |
|
|
|
|
|
|
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S R N/A |
S – Susceptible R – Intermediate or resistance N/A – Not available or not tested
Antimicrobial agent abbreviations: AMP=ampicillin, AMP-SUL=ampicillin/sulbactam, CEFZN= cefazolin, CEFEP = cefepime, CEFTAZ=ceftazidime, CEFTRX=ceftriaxone, CIPRO = ciprofloxacin, GENT=gentamicin, IMI=imipenem, LEVO=levofloxacin, LINZ = linezolid, MERO = meropenem OX/METH=oxacillin or methicillin, PIP-TAZO=piperacillin/ tazobactam, TMZ=trimethoprim/sulfamethoxazole, VANC=vancomycin
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Lisa La Place |
File Modified | 0000-00-00 |
File Created | 2021-01-23 |